Andere talen Sanara MedTech Inc.

Aandelen

SMTI

US79957L1008

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
31,23 ^USD	-1,92%		-3,91%	-24,01%

05/04	Sanara MedTech benoemt Jake Waldrop tot Chief Operating Officer	MT
05/04	Sanara MedTech Inc. kondigt Executive Changes aan, met ingang van 15 april 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates	29/04
Sanara MedTech Inc. Announces $55 Million Debt Facility	18/04
Sanara Medtech Inc. Announces $55 Million Debt Facility	18/04
Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	05/04
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer	05/04
Sanara MedTech Inc. Announces Executive Changes, Effective April 15, 2024	05/04
Earnings Flash (SMTI) SANARA MEDTECH Posts Q4 Revenue $17.7M, vs. Street Est of $16.5M	25/03
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results	25/03
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates	13/03
Sanara MedTech Reports Higher Preliminary Q4 Revenue	22/02
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023	22/02
Sanara MedTech Inc. Announces Unaudited Preliminary Net Revenue Results for the Fourth Quarter and Full-Year 2023	22/02
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides	03/01
Sanara MedTech Secures Exclusive Licensing Deal with Tufts University for 18 Collagen Peptides	03/01
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing	30/11
Sanara MedTech Q3 Loss Narrows, Revenue Rises; Shares Fall After Hours	13/11
Sanara MedTech Inc. Announces Third Quarter 2023 Results	13/11
Earnings Flash (SMTI) SANARA MEDTECH Reports Q3 Revenue $16M, vs. Street Est of $18.8M	13/11
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sanara MedTech Inc.

Aandelen

SMTI

US79957L1008

Andere talen

Filters